✦ LIBER ✦
Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib : A phase I-II study by the Spanish group for research on sarcomas
✍ Scribed by Joan Maurel; Ana Sofia Martins; Andrés Poveda; José Antonio López-Guerrero; Ricardo Cubedo; Antonio Casado; Javier Martínez-Trufero; Juan Ramón Ayuso; Antonio Lopez-Pousa; Xabier Garcia-Albeniz; Xavier Garcia del Muro; Enrique de Alava
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 403 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.